Tennessee transplant NanoDetection Technology has cashed in on the promise of an investment that drew it to Ohio earlier this year and has closed on a $2.3 million series A round of funding. The Cincinnati-area company is developing a low-cost, point-of-care diagnostic test for MRSA (Methicillin-resistant Staphylococcus aureus) to be sold to hospitals and physicians’ […]
Lured by a $2 million investment round, Tennessee diagnostic device company NanoDetection Technology is moving to Cincinnati. The new funding will allow the company to complete the clinical trials necessary to get its device on the market, which NanoDetection hopes to do in 2013.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.